Table 2.
The interaction effects of ketamine infusions on CADSS and BPRS.
| CADSS before infusion | CADSS after 40 minutes from infusion | ||||||
| M (SD) | Me (IQR) | M (SD) | Me (IQR) | Z | P | r | |
| Infusion 1 | 0.18 (0.49) | 0 (0) | 13.63 (9.14) | 14 (13) | −5.97 | <.001 | −0.85 |
| Infusion 2 | 0.35 (1.48) | 0 (0) | 14.90 (11.92) | 13 (15.5) | −5.97 | <.001 | −0.85 |
| Infusion 3 | 0.55 (2.41) | 0 (0) | 11.43 (13.14) | 8 (12) | −5.42 | <.001 | −0.77 |
| Infusion 4 | 0.27 (1.30) | 0 (0) | 11.94 (11.58) | 10 (12.5) | −5.72 | <.001 | −0.82 |
| Infusion 5 | 0.22 (0.77) | 0 (0) | 10.63 (8.04) | 9 (10.5) | −5.65 | <.001 | −0.81 |
| Infusion 6 | 0.36 (1.58) | 0 (0) | 10.15 (8.80) | 9,5 (13.5) | −4.70 | <.001 | −0.82 |
| Infusion 7 | 0.22 (1.16) | 0 (0) | 9.53 (10.27) | 6 (15) | −5.31 | <0.001 | −0.76 |
| Infusion 8 | 0.24 (1.16) | 0 (0) | 8.16 (9.04) | 5 (10) | −5.38 | <.001 | −0.77 |
| Pre-post | 0.45 (1.72) | 0 (0) | 0.90 (3.16) | 0 (0) | −0.86 | .389 | −0.12 |
| BPRS before infusion | BPRS after 40 minutes from infusion | ||||||
| M (SD) | Me (IQR) | M (SD) | Me (IQR) | Z | P | r | |
| Infusion 1 | 0.18 (0.67) | 0 (0) | 0.82 (1.50) | 0 (1) | −3.17 | .002 | −0.45 |
| Infusion 2 | 0.33 (1.07) | 0 (0) | 0.82 (1.41) | 0 (1) | −3.09 | .002 | −0.44 |
| Infusion 3 | 0.04 (0.20) | 0 (0) | 0.67 (1.95) | 0 (1) | −3.33 | .001 | −0.48 |
| Infusion 4 | 0.06 (0.32) | 0 (0) | 0.53 (0.87) | 0 (1) | −3.75 | <.001 | −0.54 |
| Infusion 5 | 0.06 (0.24) | 0 (0) | 0.59 (0.96) | 0 (1) | −3.52 | <.001 | −0.50 |
| Infusion 6 | 0.15 (0.88) | 0 (0) | 0.63 (1.10) | 0 (1) | −3.94 | <.001 | −0.69 |
| Infusion 7 | 0.02 (0.16) | 0 (0) | 0.25 (0.65) | 0 (0) | −2.27 | .023 | −0.32 |
| Infusion 8 | 0.16 (0.91) | 0 (0) | 0.39 (0.98) | 0 (0.5) | −3.05 | .002 | −0.44 |
| Pre-post | 0.24 (0.95) | 0 (0) | 0.31 (1.10) | 0 (0) | −0.97 | .334 | −0.14 |
BPRS = Brief Psychiatric Rating Scale, CADSS = Clinician-Administeredered Dissociative States Scale.